Clinical trial

Special Drug Use Surveillance of Entresto Tablets (Hypertension)

NCT05976230

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2023-09-04

PhaseN/A

Study timeline

Study start (actual)2023-09-04Date precision: day

Registry last updated2026-06-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hypertensionunresolved

Interventions

EntrestoDRUG · verified · RxNorm: Entresto

Sponsors & collaborators

Novartis Pharmaceuticalslead sponsor

Mapped research locations

YokohamaKanagawa, Japan6 FukuokaJapan5 SapporoHokkaido, Japan4 NagoyaAichi-ken, Japan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05976230 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.